Author:
Zhou Changwu,Huang Peng,Wu Fei,Xiao Yuyao,Yang Chun,Zeng Mengsu
Funder
National Science Foundation of China
Clinical Research Plan of SHDC
Science and Technology Commission of Shanghai Municipality
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Sempoux C, Kakar S, Kondo F et al (2019) Combined hepatocellular-cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO classification of tumours: digestive system tumours. 5th ed. Lyon: IARC:260–262
2. Sciarra A, ParK Y N, Sempoux C (2020) Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma. Hum Pathol 96:48-55
3. Zhou C W, Wang Y, Ma L et al (2022) Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis. Eur Radiol 32:78-88
4. Jeon S K, Joo I, Lee D H et al (2019) Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiol 29:373-382
5. Brunt E, Aishima S, Clavien PA et al (2018) cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentiation. Hepatology 68:113-126